Switching of biologic treatment to an anti-IL-5Rα agent in a patient with severe eosinophilic asthma
A 42-year-old female office worker first presented in mid-2018 with chest tightness and wheezing. Other than a past medical history of depression, she had no other comorbidities. 

New Molecule

7 New

New Indication

4 New

New Dosage Strength

1 New

Markings
Shape
Form
Color 1
Color 2
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in